Drug Search Results
More Filters [+]

PRO-087

Alternative Names: pro-087, pro087, pro 087
Latest Update: 2024-01-05
Latest Update Note: Clinical Trial Update

Product Description

For Dry Eye Syndrome

Mechanisms of Action: Type 2 Collagen Stimulant

Novel Mechanism: Yes

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Laboratorios Sophia S.A de C.V.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PRO-087

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Dry Eye Syndromes|Keratoconjunctivitis Sicca

Phase 1: Environmental Hypersensitivity|Keratoconjunctivitis Sicca|Dry Eye Syndromes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PRO-087

P4

Completed

Dry Eye Syndromes|Keratoconjunctivitis Sicca

2023-05-15

087LATAMFIV

P4

Completed

Dry Eye Syndromes|Keratoconjunctivitis Sicca

2018-10-16

PRO-087/I

P1

Completed

Keratoconjunctivitis Sicca|Environmental Hypersensitivity|Dry Eye Syndromes

2018-02-12

22%

Recent News Events

Date

Type

Title